Published in Am J Psychiatry on September 01, 1999
Human biomarkers of rapid antidepressant effects. Biol Psychiatry (2013) 1.09
Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges. Brain Res Rev (2009) 1.06
Antidepressant chronotherapeutics for bipolar depression. Dialogues Clin Neurosci (2012) 0.95
Sleep duration and depressive symptoms: a gene-environment interaction. Sleep (2014) 0.92
Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment. Psychopharmacology (Berl) (2004) 0.90
A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment. Psychosomatics (2010) 0.88
Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence. Psychopharmacology (Berl) (2003) 0.87
Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study. Indian J Psychiatry (2008) 0.86
Genetic bases of comorbidity between mood disorders and migraine: possible role of serotonin transporter gene. Neurol Sci (2009) 0.80
Validation of the Italian Version of the Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN): Some Considerations on its Screening Usefulness. Clin Pract Epidemiol Ment Health (2014) 0.76
Hypersomnia in Mood Disorders: a Rapidly Changing Landscape. Curr Sleep Med Rep (2015) 0.76
The role of sleep in bipolar disorder. Nat Sci Sleep (2016) 0.75
GABA-BZD Receptor Modulating Mechanism of Panax quinquefolius against 72-h Sleep Deprivation Induced Anxiety like Behavior: Possible Roles of Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation. Front Neurosci (2016) 0.75
Some ado about a polymorphism. Am J Psychiatry (2000) 0.75
Basic sleep and circadian science as building blocks for behavioral interventions: a translational approach for mood disorders. Behav Neurosci (2014) 0.75
The genome sequence of the plant pathogen Xylella fastidiosa. The Xylella fastidiosa Consortium of the Organization for Nucleotide Sequencing and Analysis. Nature (2000) 10.03
A systematic review of neurobiological and clinical features of mindfulness meditations. Psychol Med (2009) 2.62
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry (2008) 2.35
Tolerance and withdrawal with zolpidem. Lancet (1993) 1.97
Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. J Clin Psychiatry (2000) 1.60
Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients. Eur J Endocrinol (2011) 1.60
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol (2011) 1.59
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. Arch Gen Psychiatry (2001) 1.56
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry (1996) 1.55
Primary lactase deficiency and past malarial endemicity in Sardinia. Ital J Gastroenterol Hepatol (1998) 1.52
Sequencing and functional analysis of styrene catabolism genes from Pseudomonas fluorescens ST. Appl Environ Microbiol (1997) 1.45
Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate. J Clin Psychiatry (1999) 1.43
The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: a real-life randomised trial. Allergol Immunopathol (Madr) (2012) 1.41
Single-strand conformation polymorphism analysis of the glucose transporter gene GLUT1 in maturity-onset diabetes of the young. J Mol Med (Berl) (2001) 1.39
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis (2005) 1.35
Enzyme release from polymorphonuclear leukocyte lysosomes: regulation by autonomic drugs and cyclic nucleotides. Science (1973) 1.34
Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry (1998) 1.29
Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res (1999) 1.29
Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res (1999) 1.25
[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol (2000) 1.17
Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry (2005) 1.17
Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group. Ann Oncol (2013) 1.16
Spontaneous hypoglycemia in patients with cystic fibrosis. Eur J Endocrinol (2007) 1.15
Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia (2011) 1.15
Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry (2001) 1.11
Weight gain in antipsychotic-naive patients: a review and meta-analysis. Psychol Med (2009) 1.11
Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients. Genes Brain Behav (2007) 1.10
Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J Biol Chem (1988) 1.09
Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci (1999) 1.06
Psychiatric disorders in the families of patients with obsessive-compulsive disorder. Psychiatry Res (1992) 1.06
No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes. Diabetologia (2011) 1.05
Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res (1996) 1.03
Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry (1999) 1.02
Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol (2011) 1.02
Enzyme release from guinea-pig polymorphonuclear leucocyte lysosomes inhibited in vitro by anti-inflammatory drugs. Nat New Biol (1972) 1.02
Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res (1992) 1.01
Presence of fibronectin in articular cartilage in two animal models of osteoarthritis. J Rheumatol (1986) 1.00
How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol (1997) 1.00
Ileal carcinoid metastatic to the breast. Report of a case. Tumori (1988) 1.00
Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet (1999) 0.98
Bridge to lung transplantation by venovenous extracorporeal membrane oxygenation: a lesson learned on the first four cases. Transplant Proc (2010) 0.98
Molecular and clinical features associated with CFTR gene rearrangements in Italian population: identification of a new duplication and recurrent deletions. Clin Genet (2008) 0.97
Immunogenetics of the Lennox-Gastaut syndrome: frequency of HL-A antigens and haplotypes in patients and first-degree relatives. Epilepsia (1975) 0.97
Morning sunlight reduces length of hospitalization in bipolar depression. J Affect Disord (2001) 0.97
Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients. Biol Psychiatry (1993) 0.96
Association of the CLCA1 p.S357N variant with meconium ileus in European patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (2010) 0.95
Dose-response efficacy of paroxetine in preventing depressive recurrences: a randomized, double-blind study. J Clin Psychiatry (1998) 0.95
Biliary bile acid composition of the human fetus in early gestation. Pediatr Res (1987) 0.94
Jagged-1 mutation analysis in Italian Alagille syndrome patients. Hum Mutat (1999) 0.94
Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry (2001) 0.93
The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Res (1998) 0.93
Olanzapine-induced neutropenia after clozapine-induced neutropenia. Lancet (1999) 0.93
Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine. Drug Alcohol Depend (1994) 0.92
Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur Neuropsychopharmacol (2006) 0.92
A new in vivo assay for screening drugs for potential anti-inflammatory activity. J Clin Pharmacol J New Drugs (1967) 0.92
Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology (1990) 0.92
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Biochim Biophys Acta (1988) 0.92
'Theory' of mind impairment in patients affected by schizophrenia and in their parents. Schizophr Res (2009) 0.91
DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects. Am J Med Genet (2001) 0.90
Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment. Bipolar Disord (2000) 0.90
Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry (1996) 0.90
Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study. Int Clin Psychopharmacol (1997) 0.90
Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology (1999) 0.90
Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders. Am J Psychiatry (2001) 0.90
Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatry Res (2000) 0.89
Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency. J Pediatr Gastroenterol Nutr (1984) 0.89
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry (2001) 0.89
A new model of osteoarthritis in rabbits. III. Evaluation of anti-osteoarthritic effects of selected drugs administered intraarticularly. Arthritis Rheum (1983) 0.89
Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model? J Psychiatr Res (2001) 0.88
The occurrence of percutaneous injuries to health care workers: a cross sectional survey in seven Swiss hospitals. Schweiz Med Wochenschr (1998) 0.88
A genetic study of affective disorders. Acta Psychiatr Scand (1977) 0.88
A new model of osteoarthritis in rabbits. I. Development of knee joint pathology following lateral meniscectomy and section of the fibular collateral and sesamoid ligaments. Arthritis Rheum (1983) 0.87
Symptomatologic analysis of psychotic and non-psychotic depression. J Affect Disord (1999) 0.87
Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Mol Psychiatry (2000) 0.87
Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder. Eur Psychiatry (2011) 0.87